about  cerecor inc cerc a leading neuroscience company developing innovative therapies for multiple indications with high unmet needs about about making a difference in the lives of patients with neurological and psychiatric disorders cerecor inc is a clinicalstage biopharmaceutical company with the goal of becoming a leader in the development of innovative drugs that make a difference in the lives of patients with neurological and psychiatric disorders we systematically identify platforms and product candidates for which human proof of concept exists in the intended indication for either the target or the compound and for which biomarkers are available to measure therapeutic response view our pipeline extensive product development and commercialization experience members of our management team have extensive pharmaceutical product development and commercialization experience and have played key roles in the development or commercialization of prozac® zyprexa® cymbalta® nuplazid™ and abilify® each of which is a neuroscience product that has generated more than  billion of annual revenues or has the potential to do so collectively our officers and directors have contributed to the submission of numerous investigational new drug applications ind and nine new drug applications nda to the fda view our stock info management team board of directors company information  cerecor inc cerc company information investors company information company profile cerecor is a clinicalstage biopharmaceutical company developing innovative drug candidates to make a difference in the lives of patients with neurological and psychiatric disorders cerecor is currently pursuing the development of two clinical phase stage product candidates cerc and cerc as well as two earlier stage programs view profile view management team latest presentation investor presentation view this presentation contact information investor relations ircerecorcom company contact cerecor inc  east pratt street baltimore md  cerecor inc cerc continue improving lives making a difference at cerecor we are committed to developing drugs that have the potential to make a difference in the lives of patients with neurological and psychiatric disorders how we’re making a difference improving lives making a difference at cerecor we are committed to developing drugs that have the potential to make a difference in the lives of patients with neurological and psychiatric disorders how we’re making a difference improving lives making a difference at cerecor we are committed to developing drugs that have the potential to make a difference in the lives of patients with neurological and psychiatric disorders how we’re making a difference improving lives making a difference at cerecor we are committed to developing drugs that have the potential to make a difference in the lives of patients with neurological and psychiatric disorders how we’re making a difference home welcome to cerecor cerecor is a baltimorebased biopharmaceutical company with the goal of becoming a leader in the development of innovative drugs that make a difference in the lives of patients with neurological and psychiatric diseases about cns learn more about the cns disorders we’re targeting as well as contact information for help hotlines learn more about cns disorders backed by more than  collective years of experience the members of our team have extensive pharmaceutical product development and commercialization experience and have played key roles in the development or commercialization of prozac® zyprexa® cymbalta® nuplazid™ and abilify® view management team uli hacksell phd chief executive officer president and chairman of the board of directors view full profile ronald marcus md chief medical officer and head regulatory affairs view full profile mariam e morris cpa chief financial officer view full profile john kaiser chief business officer view full profile uli hacksell phd chief executive officer president and chairman of the board of directors dr hacksell was appointed ceo  president of cerecor inc in january of  dr hacksell also serves as chairman of the board of directors a position he has held since may of  prior to cerecor dr hacksell served as chief executive officer of acadia pharmaceuticals inc or acadia from september  to march  and was a member of its board of directors he initially joined acadia as executive vice president of drug discovery prior to acadia dr hacksell held various senior executive positions at astra ab or astra a pharmaceutical company including vice president of drug discovery and technology president of astra draco one of astra’s largest research and development subsidiaries and vice president of cns preclinical rd at astra arcus another astra subsidiary earlier in his career dr hacksell held the positions of professor of organic chemistry and department chairman at uppsala university in sweden and also served as chairman and vice chairman of the european federation of medicinal chemistry dr hacksell is currently chairman of the board of directors of glionova therapeutics and is also a member of the board of directors of index pharmaceuticals and uppsala university he received a master of pharmacy and a phd in medicinal chemistry from uppsala university ronald marcus md chief medical officer and head regulatory affairs dr marcus has served as our chief medical officer and head of regulatory affairs since may  he has more than  years of experience in the development of neuroscience drugs at both spinifex pharmaceuticals or spinifex and bristolmyers squibb dr marcus was most recently the chief medical officer at spinifex where he was responsible for driving clinical development and regulatory strategy of its lead compound for neuropathic pain prior to that dr marcus held various positions at bristolmyers squibb including group director of neuroscience strategic unit and executive director of neuroscience global clinical research in this role he was early development team leader for neuropathic pain schizophrenia and migraine compounds and lifecycle management team leader for abilify® which included the development of abilify® for the adjunctive treatment of depression he has extensive experience in early drug development and possesses both breadth and depth in all of the key functional areas of exploratory and late development disease biology and regulatory affairs dr marcus has been recognized within the biopharmaceutical industry for his excellence in overall drug development innovative strategic leadership and executional excellence while spearheading an industryleading life cycle management program for abilify® in addition to the approval of over  new drug applications nda and supplemental ndas globally for abilify® dr marcus also led the successful development of serzone® an antidepressant further dr marcus has authored more than  peerreviewed publications dr marcus received his ba in psychology from the university of virginia he earned his md from suny buffalo and completed his psychiatry residency and the national institute of mental health research fellowship at cornell university new york hospitalwestchester division mariam e morris cpa chief financial officer mariam e morris joined cerecor pharmaceuticals as chief financial officer in  leading cerecor through its initial public offering and currently serves as the company’s secretary and treasurer mariam is a seasoned financial executive and comes to cerecor with over  years of experience and having owned her own consulting firm for the past six years while consulting mariam worked with several business as outsourced cfo and cbo roles prior to owning her own firm mariam was the chief financial officer of sucampo pharmaceuticals nasdaq scmp her years of experience include strategic planning investor relations human resources internal controls for public and private companies sox compliance and oversite of human resources and information technology mariam has significant sec reporting tax acquisition technical accounting budgeting treasury operations and project management experience she has a masters in taxation from old dominion university a ba in accounting from texas tech university and is a member of the aicpa and tscpa john kaiser chief business officer mr kaiser serves as cerecors chief business officer with responsibilities for corporate strategy strategic marketing and business development and led the company to acquire both cerc and cerc in  and  respectively prior to joining cerecor mr kaiser founded denysias bioscience llc a biopharmaceutical company focused on developing new therapies for neuropsychiatric disorders where he served as chief executive officer at the same time mr kaiser also served as president of kaiser  associates consulting a boutique consulting firm providing strategic corporate and commercial expertise to the biopharmaceutical industry from  mr kaiser served as vice president of commercial and business development at acadia pharmaceuticals inc before acadia mr kaiser held numerous positions of increasing responsibilities in sales marketing and general management at eli lilly and company in a career of more than  years at lilly mr kaiser led the global commercialization efforts of prozac® the global strategic marketing efforts for cymbalta® and helped drive the commercial success of zyprexa® internationally mr kaiser also led the strategic marketing efforts for the companys cns development portfolio and coled the development and execution of the companys cns strategy mr kaiser is a member of cerecors senior management team and currently serves on the board of directors of nhtherapeutics mr kaiser received his bs in pharmaceutical sciences from the james l winkle college of pharmacy at the university of cincinnati recent news may   •  am edt cerecor to present at the american society for clinical psychopharmacology conference may   •  am edt cerecor appoints steven boyd and peter greenleaf to board of directors view all news investor relations cerecor inc nasdaq cerc symbol price change volume day range  week range latest investor presentation view latest k view investor relations cerecor inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies market research report cerecor inc  product pipeline review   published by global markets direct product code  published december   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license cerecor inc  product pipeline review   published december   content info  pages description summary global markets directs cerecor inc  product pipeline review   provides an overview of the cerecor incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of cerecor incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of cerecor inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of cerecor incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the cerecor incs pipeline products reasons to buy evaluate cerecor incs strategic position with total access to detailed information on its product pipeline assess the growth potential of cerecor inc in its therapy areas of focus identify new drug targets and therapeutic classes in the cerecor incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of cerecor inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of cerecor inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of cerecor inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures cerecor inc snapshot cerecor inc overview key information key facts cerecor inc  research and development overview key therapeutic areas cerecor inc  pipeline review pipeline products by stage of development pipeline products  monotherapy cerecor inc  pipeline products glance cerecor inc  clinical stage pipeline products phase ii productscombination treatment modalities cerecor inc  early stage pipeline products preclinical productscombination treatment modalities cerecor inc  drug profiles cerc product description mechanism of action rd progress memantine hydrochloride product description mechanism of action rd progress mppa product description mechanism of action rd progress small molecules to inhibit comt for cognitive disorders product description mechanism of action rd progress cerecor inc  pipeline analysis cerecor inc  pipeline products by target cerecor inc  pipeline products by route of administration cerecor inc  pipeline products by molecule type cerecor inc  pipeline products by mechanism of action cerecor inc  recent pipeline updates cerecor inc  dormant projects cerecor inc  discontinued pipeline products discontinued pipeline product profiles cerc cerecor inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables cerecor inc key information cerecor inc key facts cerecor inc  pipeline by indication  cerecor inc  pipeline by stage of development  cerecor inc  monotherapy products in pipeline  cerecor inc  phase ii  cerecor inc  preclinical  cerecor inc  pipeline by target  cerecor inc  pipeline by route of administration  cerecor inc  pipeline by molecule type  cerecor inc  pipeline products by mechanism of action  cerecor inc  recent pipeline updates  cerecor inc  dormant developmental projects cerecor inc  discontinued pipeline products  list of figures cerecor inc  pipeline by top  indication  cerecor inc  pipeline by stage of development  cerecor inc  monotherapy products in pipeline  cerecor inc  pipeline by top  target  cerecor inc  pipeline by top  route of administration  cerecor inc  pipeline by top  molecule type  cerecor inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved cerc key statistics  cerecor inc financial ratios  marketwatch bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close cerecor inc nasdaq cerc go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus cerecor inc market closed  quotes are delayed by  min jul    pm cerc quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description cerecor inc is a clinical stage biopharmaceutical company focuses in medical development it involves in the discovery manufacture and commercialization of prescription for neurological and psychiatric disorders it products include cerc cerc cerc and cerc the company was foun cerecor inc is a clinical stage biopharmaceutical company focuses in medical development it involves in the discovery manufacture and commercialization of prescription for neurological and psychiatric disorders it products include cerc cerc cerc and cerc the company was founded by blake m paterson isaac blech barbara s slusher and solomon h snyder on january   and is headquartered in baltimore md valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure total debt to total equity  total debt to total capital  total debt to total assets  officers and executives name age officer since title dr uli hacksell   chairman president  chief executive officer ms mariam e morris   cfo  principal accounting officer mr john joseph kaiser   chief business officer mr peter s greenleaf   director mr steven joseph boyd   director insider actions – purchase – sale  – number of transactions  date name shares transaction value  armistice capital llc director    derivativenonderivative trans at  per share   armistice capital llc director    derivativenonderivative trans at  per share   armistice capital llc director    derivativenonderivative trans at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share   armistice capital llc director    acquisition at  per share  newslatestcompanyuscerc marketwatch news on cerc ciao euro global markets gird for the next wave of global populism  pm dec    shawn langlois cerecor inc shares drop  after midstage trial failure  am dec    emma court cerecors stock extends slide plunges  premarket after failed drug trial  am dec    tomi kilgore cerecor says midstage trial of treatment for nicotine withdrawal missed its target  am dec    ciara linnane cerecors stock tumbles  premarket after drug trial fails to meet primary endpoint  am dec    tomi kilgore cerecors stock on track to open at alltime low  am dec    tomi kilgore newsnonmarketwatchcompanyuscerc other news on cerc air products  chemicals inc apd and united security bancshares usbo lead  investor filings  am may    investorplacecom insiderinsightscom daily round up  rev opk rdus  am may    seeking alpha centurylink inc ctl tripadvisor inc trip lead  notable investor filings  pm may    investorplacecom q cerecor inc  am may    edgar online  edg  q k cerecor closes private placement of common stock at  a share shares down   am april    seeking alpha k cerecor inc  pm march    edgar online  edg  q k  pharmaceuticals stocks to sell now  am dec    investorplacecom cerecors cerc flunks midstage study shares off   am dec    seeking alpha biggest movers in manufacturing stocks now – csbr nvet crr hes  am nov    investorplacecom cerecors lead product candidate flunks midstage study in mdd shares plummet  after hours  pm nov    seeking alpha hottest manufacturing stocks now – enta ktec mov mt  am nov    investorplacecom cerecors trial of cerc in depression offers investors potential upside  pm nov    seeking alpha q cerecor inc  pm nov    edgar online  edg  q k alkermes buying ripples out to cerecor shares up   am oct    seeking alpha hottest manufacturing stocks now – alks cerc tvia ptx  am oct    investorplacecom hottest manufacturing stocks now – mbrx ipci tanh mtl  am oct    investorplacecom biggest movers in manufacturing stocks now – cerc kmg asmb sky  pm oct    investorplacecom biggest movers in manufacturing stocks now – abeo cris mdgl edge  pm oct    investorplacecom hottest manufacturing stocks now – pzrx coll idra lpcn  pm sept    investorplacecom cerecor nabs rights to epilepsy candidate from eli lilly  pm sept    seeking alpha loading more headlines at a glance cerecor inc  east pratt street suite  baltimore maryland  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue m net income m employees  annual report for cerc newspressreleasecompanyuscerc press releases on cerc cerecor to present at the american society for clinical psychopharmacology conference  am may    marketwired cerecor appoints steven boyd and peter greenleaf to board of directors  am may    marketwired cerecor inc reports first quarter  financial results  am may    marketwired cerecor reports encouraging topline data from a nih sponsored proofofconcept trial of cerc in treatmentresistant depression  am may    marketwired cerecor inc closes  million private placement  am april    marketwired cerecor inc reports financial results for the fourth quarter and year ended december    am march    marketwired cerecor engages suntrust robinson humphrey to assist with review of strategic alternatives  am feb    marketwired cerecor announces atthemarket equity offering program  pm jan    marketwired cerecor announces topline results from cerc phase  study for nicotine withdrawal  am dec    marketwired cerecor reports topline data from cerc phase  study for major depressive disorder  pm nov    marketwired cerecor inc reports third quarter  financial results  am nov    marketwired discovery of cerecor drug candidate cerc ly published in nature medicine  pm nov    marketwired cerecor to present at the th annual bio investor forum in san francisco on october th   am oct    businesswire  bzx cerecor announces acquisition of tarpampa receptor antagonist cerc from lilly  am sept    businesswire  bzx cerecor announces completion of enrollment in phase  clinical trial with cerc as an oral adjunctive treatment of major depressive disorder  am sept    businesswire  bzx cerecor enters into a  million common stock purchase agreement with aspire capital fund llc  am sept    businesswire  bzx cerecor announces last patient enrolled in phase  clinical trial with cerc for smoking cessation  am sept    businesswire  bzx cerecor to present at rd annual newsmakers in the biotech industry conference in new york city september    am sept    businesswire  bzx cerecor inc announces initiation of second cerc phase  clinical trial in smokers  am aug    businesswire  bzx cerecor to present at the th annual rodman  renshaw global investment conference in new york city september th   am aug    businesswire  bzx loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pscaramucci says trump’s love of pizza shows he’s not an elitist —  ways rich people act humble pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss phere are  coworkers you should avoid like the plague in meetings pone depressing reason millions of people are locked out of the american dream pa provocative new analysis suggests you don’t have to take all your antibiotics after all pintel earnings have message for amd and nvidia ‘bring it on’ pamazon’s freespending ways hit earnings but don’t expect a shift to thrift predfin prices ipo higher than expected for  billion valuation pspacex valuation jumps to  billion on new financing round phoward marks says bitcoin isn’t real—and we can all blame millennials for its rise pheadline sen graham the skinny bill is a disaster psenate passes russia sanctions bill on  vote pscaramucci provides a shocking bannon comparison that defies anatomy pethereum struggles to rise as regulatory scrutiny weighs on digital currency pthis fund strategist says there’s at least one way companies can survive amazon’s onslaught pthis basic balanced index fund is beating the hedge fund averages ptesla earnings will model  live up to the hype pwhat a constant stream of oil company spending cuts means for crude prices pall the companies in jeff bezos’s empire in one large chart pbitcoin investors things may get very ugly soon if this chart overlay is right loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  investor relations  cerecor inc cerc investor relations investors investor relations latest news view all news may   •  am edt cerecor to present at the american society for clinical psychopharmacology conference stock information view detailed stock information nasdaq cerc cerecor inc price change volume day range  week range company overview cerecor is a clinicalstage biopharmaceutical company developing innovative drug candidates to make a difference in the lives of patients with neurological and psychiatric disorders cerecor is currently pursuing the development of two clinical phase stage product candidates cerc and cerc as well as two earlier stage programs view latest presentation sec filings corporate governance cerecor inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports cerecor inc  product pipeline review   cerecor inc  product pipeline review   wgr  december  global  pages global markets direct description table of content sample report enquiry before buy related reports cerecor inc  product pipeline review  summaryglobal markets direct’s ‘cerecor inc  product pipeline review  ’ provides an overview of the cerecor inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of cerecor inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of cerecor inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of cerecor inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the cerecor inc’s pipeline productsreasons to buy evaluate cerecor inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of cerecor inc in its therapy areas of focus identify new drug targets and therapeutic classes in the cerecor inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of cerecor inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of cerecor inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of cerecor inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures cerecor inc snapshot cerecor inc overview key information key facts cerecor inc  research and development overview key therapeutic areas cerecor inc  pipeline review pipeline products by stage of development pipeline products  monotherapy cerecor inc  pipeline products glance cerecor inc  clinical stage pipeline products phase ii productscombination treatment modalities cerecor inc  early stage pipeline products preclinical productscombination treatment modalities cerecor inc  drug profiles cerc product description mechanism of action rd progress memantine hydrochloride product description mechanism of action rd progress mppa product description mechanism of action rd progress small molecules to inhibit comt for cognitive disorders product description mechanism of action rd progress cerecor inc  pipeline analysis cerecor inc  pipeline products by target cerecor inc  pipeline products by route of administration cerecor inc  pipeline products by molecule type cerecor inc  pipeline products by mechanism of action cerecor inc  recent pipeline updates cerecor inc  dormant projects cerecor inc  discontinued pipeline products discontinued pipeline product profiles cerc cerecor inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablescerecor inc key information cerecor inc key facts cerecor inc  pipeline by indication  cerecor inc  pipeline by stage of development  cerecor inc  monotherapy products in pipeline  cerecor inc  phase ii  cerecor inc  preclinical  cerecor inc  pipeline by target  cerecor inc  pipeline by route of administration  cerecor inc  pipeline by molecule type  cerecor inc  pipeline products by mechanism of action  cerecor inc  recent pipeline updates  cerecor inc  dormant developmental projects cerecor inc  discontinued pipeline products  list of figurescerecor inc  pipeline by top  indication  cerecor inc  pipeline by stage of development  cerecor inc  monotherapy products in pipeline  cerecor inc  pipeline by top  target  cerecor inc  pipeline by top  route of administration  cerecor inc  pipeline by top  molecule type  cerecor inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send cerecor inc  product pipeline review   sales and support     uk     us infomarketpublisherscom business  finance retail retail consumer goods food  beverage industry chemicals it  technology life sciences medical devices anesthesia  respiratory cardiovascular devices dental diabetes care diagnostic equipment drug delivery endoscopy ear nose  throat ent healthcare equipmentsupplies company reports implants neurology orthopedic ophthalmic surgical equipment wound closure other medical devices biotechnology biomarkers biomaterials biosimilars stem cell diagnostics  diseases in vitro diagnostics incontinence cancer cardiovascular diabetes hepatitis healthcare healthcare services company reports ear care eye care hospital medicated skin care therapy wound care pharmaceuticals clinical trial drug stores drugs pharmaceuticals company reports vaccines medical products veterinary services about faq my cart market reports pressreleases events about us terms  conditions customer faq market research reports life sciences pharmaceuticals cerecor inc  product pipeline review   date december   pages  price us  license  singleuser license  us  site license  us  enterprisewide license  us  publisher global markets direct report type company report delivery email delivery pdf id cfdbben leaflet download pdf leaflet abstracts contents list of tables list of figures cerecor inc  product pipeline review  summaryglobal markets direct’s ‘cerecor inc  product pipeline review  ’ provides an overview of the cerecor inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of cerecor inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of cerecor inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of cerecor inc’s human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones special feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statement latest news and deals relating to the cerecor inc’s pipeline productsreasons to buyevaluate cerecor inc’s strategic position with total access to detailed information on its product pipelineassess the growth potential of cerecor inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the cerecor inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of cerecor inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of cerecor incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of cerecor inc and identify potential opportunities in those areasavoid intellectual property rights related issues cerecor inc snapshotcerecor inc overviewkey informationkey factscerecor inc  research and development overviewkey therapeutic areascerecor inc  pipeline reviewpipeline products by stage of developmentpipeline products  monotherapycerecor inc  pipeline products glancecerecor inc  clinical stage pipeline productsphase ii productscombination treatment modalitiescerecor inc  early stage pipeline productspreclinical productscombination treatment modalitiescerecor inc  drug profilescercproduct descriptionmechanism of actionrd progressmemantine hydrochlorideproduct descriptionmechanism of actionrd progressmppaproduct descriptionmechanism of actionrd progresssmall molecules to inhibit comt for cognitive disordersproduct descriptionmechanism of actionrd progresscerecor inc  pipeline analysiscerecor inc  pipeline products by targetcerecor inc  pipeline products by route of administrationcerecor inc  pipeline products by molecule typecerecor inc  pipeline products by mechanism of actioncerecor inc  recent pipeline updatescerecor inc  dormant projectscerecor inc  discontinued pipeline productsdiscontinued pipeline product profilescerccerecor inc  locations and subsidiarieshead officeappendixmethodologycoveragesecondary researchprimary researchexpert panel validationcontact usdisclaimer list of tablescerecor inc key informationcerecor inc key factscerecor inc  pipeline by indication cerecor inc  pipeline by stage of development cerecor inc  monotherapy products in pipeline cerecor inc  phase ii cerecor inc  preclinical cerecor inc  pipeline by target cerecor inc  pipeline by route of administration cerecor inc  pipeline by molecule type cerecor inc  pipeline products by mechanism of action cerecor inc  recent pipeline updates cerecor inc  dormant developmental projectscerecor inc  discontinued pipeline products  list of figurescerecor inc  pipeline by top  indication cerecor inc  pipeline by stage of development cerecor inc  monotherapy products in pipeline cerecor inc  pipeline by top  target cerecor inc  pipeline by top  route of administration cerecor inc  pipeline by top  molecule type cerecor inc  pipeline products by top  mechanism of action  skip to top more publications beech tree labs inc  product pipeline review   us  may  ·  pages chemocentryx inc  product pipeline review   us  sep  ·  pages protalix biotherapeutics inc  product pipeline review   us  nov  ·  pages ask your question cerecor inc  product pipeline review   company name contact person phonefax email request invoice your enquiry please click on a check box below to confirm you are not a robot market reports all categories biotechnology biomarkers biomaterials biosimilars stem cell diagnostics  diseases in vitro diagnostics incontinence cancer cardiovascular diabetes hepatitis healthcare healthcare services company reports ear care eye care hospital medicated skin care therapy wound care medical devices anesthesia  respiratory cardiovascular devices dental devices diabetes care diagnostic equipment endoscopy ear nose  throat ent devices healthcare equipmentsupplies company reports neurology orthopedic devices ophthalmic surgical equipment wound closure other medical devices medical products pharmaceuticals clinical trials drug stores drugs pharmaceuticals company reports vaccines veterinary sales and support         infomarketpublisherscom   marketpublisherscom about us our clients our publishers customer faq market reports new publications reports by regions pressreleases terms  conditions privacy policy return policy affiliate program join as publisher follow us cerecor inc  supplier  peru  import genius plans limited plus premium limitedmonitor your competitors data access data on us ocean freight imports from the last  months for all companies youll have access to data from the previous months from the date of your search we use a rolling date range so you can always look back  months from the current date limitedmonitor your competitors data access data on us ocean freight imports from the last  months for all companies access data on us ocean freight imports from the last  months for all companies youll have access to data from the previous months from the date of your search we use a rolling date range so you can always look back months from the current date plussmall  medium business data access data on us ocean freight imports from the last  months for all companies youll have access to data from the previous months from the date of your search we use a rolling date range so you can always look back months from the current date us ocean freight exports from january   to present for all companies premium empire builder data access data on us ocean freight imports from november  to the present for all companies youll have access to our entire database of shipping manifests of us ocean freight imports going back to november  us ocean freight exports from january   to present for all companies limitedmonitor your competitors usage track the shipping activities of your  chosen companies our limited plan lets you monitor the shipping activities of any three companies across all our databases be the first to know when your target company clears a shipment through customs in one of the countries we track  contact info requests per month our team of account managers and research assistants will help you find contact information for up to  companies in our database each month download csv and xls k records per month if youre planning to do more indepth research on the companies in our database you should upgrade to the plus or premium plans which allow more downloads email alerts for up to  searches if you need to track more than  companies product segments or trade lanes you should upgrade to the plus or premium plan which allow more email alerts limitedmonitor your competitors usage  company searches per day  searches per day may be enough if you are just monitoring a few competitors or researching suppliers in a single industry if youre looking to connect with sales leads or do more indepth research you should upgrade to the plus or premium plan which allows more searches  contact info requests per month our team of account managers and research assistants will help you find contact information for up to  companies in our database each month download csv and xls k records per month if youre planning to do more indepth research on the companies in our database you should upgrade to the plus or premium plan which allow more downloads email alerts for up to  company searches if you need to track more than  companies product segments or trade lanes you should upgrade to the plus or premium plan which allow more email alerts plus small  medium business usage  searches per day  searches per day may be enough if you are just monitoring a few competitors or researching suppliers in a single industry if youre looking to connect with sales leads or do more indepth research you should upgrade to the premium plan which allows more searches  contact info requests per month our team of account managers and research assistants will help you find contact information for up to  companies in our database each month download csv and xls k records per month if youre planning to do more indepth research on the companies in our database you should upgrade to the premium plan which allow more downloads email alerts for up to  searches if you need to track more than  companies product segments or trade lanes you should upgrade to the premium plan which allow more email alerts premium empire builder usage  searches per day    contact info requests per month our team of account managers and research assistants will help you find contact information for up to  companies in our database each month download csv and xls k records per month if youre planning to do more indepth research on the companies in our database contact the sales department to purchase more credits and export additional shipping records email alerts for up to  searches plus small  medium business features visual mapping our visual mapping technology provides an instant snapshot of any companys trade connections navigate the global web of trading partners with the click of a mouse and visualize the relationships between companies many degrees apart premium empire builder features visual mapping our visual mapping technology provides an instant snapshot of any companys trade connections navigate the global web of trading partners with the click of a mouse and visualize the relationships between companies many degrees apart limited monitor your competitors support our customer service agents are available when you need them call in to receive helpful tips and training call or email our customer service agents they will get back to as soon as possible to assist you with your data needs plus small  medium business support our customer service agents are available when you need them call in to receive helpful tips and training call or email our customer service agents they will get back to as soon as possible to assist you with your data needs premium empire builder support our customer service agents are available when you need them call in to receive helpful tips and training call or email our customer service agents they will get back to as soon as possible to assist you with your data needs dedicated research assistant an experienced trade data specialist will serve as your dedicated account manager to locate hardtoreach data perform searches and compile reports on your behalf limited monitor your competitors data access data on us ocean freight imports from the last  months for all companies youll have access to data from the previous months from the date of your search we use a rolling date range so you can always look back  months from the current date x home how it works us data additional countries our datasets our clients ig reviews videos pictures presentation plans  pricing search contact us live chat free demo sign in join now english  french english  french service   sales  live chat choose language english  french hi may i help you with something an importgeniuscom sales agent is available to answer your question chat live now no thanks sign up home how it works plans  pricing search contact us live chat  cerecor inc cerecor inc is an overseas supplier in united states that exports products to icon clinical research peru sa via new yo call     import genius our bill of lading data reveals the trading activities of cerecor inc and millions of other manufacturers learn more join now request a demo would you like to schedule a free demo wed love to show you international trade data relevant to your own business name email phone schedule a free demo play muted international trade starts with our data other companies in our database amplivox ltd solari internacional srltda dee india import and export sociedad anonima cerrada  dee india osteosys co ltd lamex foods inc normandale lake blvdsuite  view sample shipment records shipment alert subscription contact this company sign up sample shipment record for cerecor inc cerecor inc is an overseas supplier in united states that exports products to icon clinical research peru sa via new yo bill of lading manufacturer  shipper consignee cerecor inc icon clinical research peru sa acquisition embarkation estados unidos new yo product description grabadora philips lfh grabadora philips lfh other information available hs code description fob usd freight usd insurance usd package type net weight arrival datehs codecustomsaerea del callaoquantity  unitunidad subscribe to access the complete shipping history for cerecor inc join now how will your business use our trade data if youre involved in international trade our database of shipping manifests will help you find opportunities to grow your business find trading partners you can trust monitor competitors shipping activities connect with sales prospects very informative and great site and so quick pretty slick betty fatzie president lab products inc the service was great with a reasonable price and great results we have now started using another supplier from china we just ordered our first container from the new supplier and with the savings it more than paid for the importgeniuscom service on the first container load cleve kurz gifford monument works import genius is not merely an investment for our organization it’s a vital instrument to effectively manage our time it has afforded us the ability to quickly segment target and position ourselves in front of prospective clients thank you import genius david bryant director of business development john s james co import genius data is fantastic for evaluating component manufacturers in china sanjay dastoor boostedboardscom we have confidence that were working with the best manufacturers in part because import genius showed us that they already supply some of the worlds top brands yaniv masjedi vice president nextivacom import genius is a highly informative tool for monitoring public companies operating activities it is an invaluable part of our research eric delamarter managing partner half moon capital we find new clients for our customs brokerage in the importgenius database almost every day jayson gispan customs brokerage operations manager flexportcom importgenius is a great research tool we use it to evaluate manufacturers to make sure we are working with only the highest quality most reliable suppliers chris friedland founder  ceo buildcom importgenius gave us visibility into the actual shipping histories of the manufacturers we were evaluating and helped us feel comfortable we were working with the best suppliers in china morena simitic coo bellabeatcom shipment alert subscription receive free shipment alerts by email whenever cerecor inc clears a shipment through customs processing please wait  submit contact cerecor inc name business email phone submit processing please wait    features save and share reports easily get your searches out of import genius and into your team’s hands for further analysis export your findings to xls or csv or send reports via email it’s the simple things that make our trade data even more valuable to you see the supply chain visual mapping shows you exactly how your target companies and their trading partners connect search by shipper and see everyone they’ve shipped to or search by consignee and see all their suppliers zoom in on any company to see their own trading network dive deep into international trade and discover the links in anyone’s supply chain get realtime shipment alerts stay on top of your competitors suppliers and customers with realtime alerts just set up a search and get an email whenever a new shipment matches your terms import genius lets you know the moment they bring in a rival product or start shipping to a new partner cerecor inc youve viewed  profile pages on import genius which is the most we allow for free sign up for importgenius to get more details on over  million importers and exporters it only takes seconds sign up for import genius plans limited monitor your competitors recommended plan plus small  medium business premium empire builder price    month for  months sign up    month for  months sign up    month for  months sign up data access data on us ocean freight imports from the last  months for all companies view details access data on us ocean freight imports from the last  months for all companies us ocean freight exports from january   to present for all companies view details access data on us ocean freight imports from november  to the present for all companies us ocean freight exports from january   to present for all companies view details usage track the shipping activities of your  chosen companies  contact info requests per month download csv and xls k records per month email alerts for up to  searches view details  searches per day  contact info requests per month download csv and xls k records per month email alerts for up to  searches view details  searches per day  contact info requests per month download csv and xls k records per month email alerts for up to  searches view details features   visual mapping view details visual mapping view details support our customer service agents are available when you need them call in to receive helpful tips and training view details our customer service agents are available when you need them call in to receive helpful tips and training view details our customer service agents are available when you need them call in to receive helpful tips and training dedicated research assistant view details view all us imports instantly search  ocean freight records to monitor us importers research suppliers generate sales leads and more as featured in what is import genius who uses import genius available data fields schedule live demo what is import genius import genius reveals the trading activities of importers and exporters around the world we give you hard data about your overseas suppliers and domestic competitors using shipping databases from customs agencies in the united states latin america and india import genius can help you find reliable new trading partners monitor your competitors’ shipments and keep an eye on your current suppliers and customers our team of seasoned importexport veterans cuttingedge software developers and customer service professionals has worked for years to build the worlds most powerful and accessible database of international trade intelligence we do this for a diverse client base that requires keen insight into international trade our customers include some of the worlds top importers exporters freight forwarders logistics companies manufacturers investment banks financial analysts intellectual property attorneys and more they use our tools to research the trade activity of importers and suppliers identify and vet new sources for any kind of product monitor the competition and their trade connections generate sales leads for transportation and logistics companies track the activity of publiclytraded companies investigate and enforce intellectual property infringement ensure exclusive agent compliance who uses import genius sourcing professionals use our service to view shipping histories for suppliers we provide access to detailed customs records letting you verify suppliers true shipping volumes and us customer lists you can also look up your competing import firms to find where they buy their goods  learn more competitive intelligence analysts use our service to learn where rivals source products we give clear insights into the importing volumes new product releases and broader competitive dynamics of your industry  learn more sales  marketing teams use our service to generate sales prospects we give you the tools to target importers based on product type location shipping volumes and more  learn more financial analysts use our service to monitor public companies imports we offer rare data on the success or failure of new product launches shipping trends and other operating data for companies in any industry  learn more available data fields import genius data fields by collecting the ocean freight bill of lading for all us imports in our database import genius provides unprecedented access to near realtime information on virtually every industry and company importing goods into the country for each shipment entering the us by ocean we provide access to the following information additional fields available for some shipments phone number fax number email contact person list of data fields consigneethe company importing the shipment into the usconsignee addressthe address of the company importing the shipment into the usshipperthe overseas company exporting the shipment to the usshipper addressthe address of the overseas company exporting the shipment to the usproduct descriptionthe exporters description of the shipment as it appears on the bill of lading or shipping manifestgross weightthe gross weight of the shipment excluding the weight of the actual container this can appear in either pounds or kilograms at the discretion of the exporternumber of unitsthe quantity of boxes customs would find if they were to open the shipment for inspectionvolumethe volume of the shipment generally defined in cubic meters or container base measurements cbmarrival datethe date the shipment arrives within the customs territory of the usforeign portthe last port the shipment passes through before arriving in the uscountry of originthe country of the last foreign port the shipment passes through before arriving in the usus portthe us port where the shipment enters the customs territory of the uscarrier codethe four digit standard carrier alpha code of the ocean carrier or freight forwarder managing the transit of the shipmentvoyage numbera unique code assigned to that particular sailing of the ship between two portsvessel namethe name of the ship transporting the shipmentship registered inthe country where the ship is officially registeredbill of lading numberthe unique number assigned to this particular shipment by the ocean carrier or freight forwardercontainer numberthe unique number assigned to the ocean shipping container carrying the shipment in questionmarks  numbersany text or numbers appearing on the cartons ready for a live demo fill out this form and well contact you right away to set up a live demo of import genius schedule live demo processing please wait  name tell us your full name email enter a valid email address phone enter valid phone number preferred date let us know your preferred date preferred time in your country  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm let us know your preferred time country required timezone required what data are you interested in let us know what you are most interested to learn submit import genius how it works plans  pricing our trade data blog search latin trade data import genius reviews  press coverage who uses import genius contact us latest posts trump properties have… solar panels imports… limited plan now available chilean salmon exports… india us palm oil imports… company profiles emerson network power srl rts automation sac rimachi jimenez americo precision material handling equipment carlessi sac    records in our database and counting customer support team tel  international   fax   infoimportgeniuscom  e pima center pkwy suite  scottsdale az  shanghai china tel  mobile no  fax number  shenzhen china tel  mob  fax  have questions well reply quickly type your info below message submit processing please wait    trainings demos and general contact all available or call us service  sales  back to top all rights reserved copyright   trade data services inc  were offline please leave us a message to chat with a representative of import genius your browser needs to be internet explorer  or higher please fill out the form below and a representative will contact you as soon as possible name email phone message send x